Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery

Intrathecal Morphine (ITM) has been evaluated as a component of multimodal pain management to enhance recovery after laparoscopic colorectal surgery within the framework of Enhanced Recovery After Surgery (ERAS). Postoperative pain, particularly visceral pain, is a significant challenge to early mobilization and optimal recovery following minimally invasive colorectal procedures. The study in question investigates whether adding ITM to transversus abdominis plane block (TAPB) improves postoperative recovery outcomes.

### Study Design:

• **Type:** Prospective, double-blind randomized clinical trial.
• **Participants:** 252 adult patients undergoing elective laparoscopic colorectal surgery.
• **Intervention:** Patients were randomized to receive either ITM (3 μg/kg) or intrathecal saline placebo, with both groups receiving TAPB using liposomal bupivacaine.
• **Primary Outcome:** Quality of recovery at 24 hours, assessed via the Quality of Recovery-15 (QoR-15) score.
• **Secondary Outcomes:** Postoperative pain levels, opioid consumption, gastrointestinal recovery, adverse events, and length of hospital stay.

### Key Findings:

1. **Improved Recovery Quality:**

• Patients receiving ITM combined with TAPB demonstrated significantly better recovery at 24 hours, with higher QoR-15 scores.
• Clinically meaningful improvements were observed across multiple recovery domains.

2. **Pain Management:**

• The ITM group experienced lower postoperative pain scores compared to the control group.
• Reduced opioid requirements were noted, which is particularly beneficial as opioid-related adverse effects can hinder recovery.

3. **Enhanced Functional Recovery:**

• Faster ambulation and earlier return of bowel function were observed in the ITM group.
• Gastrointestinal recovery was significantly improved, supporting quicker progression through postoperative milestones.

4. **Adverse Effects:**

• Nausea, vomiting, and dizziness were less frequent among patients receiving ITM.
• Pruritus (itching) was more common in the ITM group but was generally manageable and non-serious.

5. **Length of Hospital Stay:**

• While specific data regarding hospital stay duration is not detailed, the faster recovery and reduced complications suggest potential for earlier discharge.

### Conclusion:

The study concludes that intrathecal morphine, when combined with TAPB, significantly enhances early postoperative recovery and analgesia after laparoscopic colorectal surgery. This approach aligns well with the principles of ERAS by promoting early mobilization, reducing opioid-related side effects, and improving overall recovery quality. Despite a higher incidence of pruritus, ITM's benefits outweigh this manageable side effect, making it an effective addition to multimodal pain management strategies.

### Clinical Implications:

• ITM combined with TAPB offers a promising strategy for addressing postoperative pain and recovery challenges in laparoscopic colorectal surgery.
• Incorporating ITM into ERAS protocols may improve patient outcomes, reduce opioid dependency, and expedite recovery timelines.
• Careful monitoring and management of pruritus are necessary to optimize patient comfort and satisfaction.

This study highlights the importance of multimodal analgesia in surgical recovery and supports ITM as a valuable tool for enhancing patient care in minimally invasive colorectal procedures.